Nocera is trading at $1.70 (7.1% down) following a 1-for-30 reverse stock split and a new strategic Letter of Intent (LOI) with INERGX.

  • The company recently filed an S-3 for a $100 million equity purchase facility, sparking dilution concerns that are weighing on the stock after its sharp post-split rally.
  • The decline follows a period of high volatility after the company completed its 1-for-30 reverse stock split last week.
  • Investors are balancing the potential growth from the INERGX partnership against the impact of the massive equity facility.